Quick Links

Credit Designation

This activity is approved for AMA PRA Category 1 Credit™.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Lilly.

For further information concerning Lilly grant funding, visit

Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

3rd Annual School of Gastrointestinal Oncology™ (SOGO™)

3rd Annual School of Gastrointestinal Oncology™ (SOGO™)

Saturday, April 28, 2018
New York, NY Times Square
300 W 44th St, New York, NY 10036
(212) 803-4500


In 2017, groundbreaking research continues to revolutionize treatment approaches and modalities across oncology disciplines. Within the diverse specialties of surgical, medical, and radiation oncology, a conference for clinicians who manage some of the most difficult-to-treat forms of gastrointestinal (GI) cancers is of particular value. The School of Gastrointestinal Oncology™ (SOGO™), a program focused exclusively on these tumors, takes the latest advances in research, and provides an educational venue that facilitates the practical application of new evidence to improve outcomes in your patients. This intensive 1-day, multi-track, curriculum-based, conference demonstrates how the latest data can be seamlessly incorporated into contemporary practice settings where patients with GI cancers receive care.

SOGO™ prides itself on its multidisciplinary focus, featuring multiple break out tracks dedicated to medical, surgical, and radiation oncology, as well as a nursing track. Attendees are brought together repeatedly throughout the day, allowing for a shared learning experience in sessions that aim to address your most difficult clinical scenarios. Now in its third year, our expert faculty will integrate the latest data on prognostic and predictive markers and how these data impact clinical decision-making on evolving treatment strategies into a case-based format. Our goal is your goal, to optimize outcomes for each one of your patients with GI cancers. See you in New York!

What you’ll learn at SOGO™ 2018!

  • How disease pathology and actionable biomarkers inform clinical decision-making
  • Advances in surgery including new frontiers in minimally invasive techniques
  • The expanding role that molecularly targeted and immunotherapeutic approaches are playing in GI cancers treatment
  • Optimized sequencing strategies to personalize care for your patients
  • Contemporary use of multidisciplinary approaches to optimize patient outcomes in advanced forms of GI cancers

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Lilly.

For further information concerning Lilly grant funding, visit

Target Audience

This educational program is directed toward oncologists and gastroenterologists whose primary practice focus is gastrointestinal (GI) cancers, and who intend to reinforce their knowledge base and expand their expertise in GI diagnosis, risk stratification, personalization of care, and best practices for multidisciplinary communication. Participants will be primarily oncologists, gastroenterologists, or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of GI cancers.

Program Co-Chairs

John Marshall, MD
Chief, Division of Hematology/Oncology
Georgetown University Hospital
Director, Ruesch Center for the Cure of GI Cancers
Washington, DC

Michael A Choti, MD, MBA, FACS
Professor and Chair
Department of Surgery
UT Southwestern Medical Center
Dallas, TX

Become a Member

Forgot Password?
Calendar of Events
Filter By